Pure Global

JAK2 V617F Mutation RT-PCR Detection Kit - India CDSCO Medical Device Registration

JAK2 V617F Mutation RT-PCR Detection Kit is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2020/000166_9a3b013c87371640d4d3dbbbf7c0e674_f866e862d7b0d5afbccfc249640bb154. This device is marketed under the brand name NeoDx. The license holder is NeoDx Biotech Labs Pvt Ltd, and it is classified as Device Class Class C. The approving authority is Sub Zonal Bangalore.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
JAK2 V617F Mutation RT-PCR Detection Kit
UID: MFG/IVD/2020/000166_9a3b013c87371640d4d3dbbbf7c0e674_f866e862d7b0d5afbccfc249640bb154

Brand Name

NeoDx

Device Class

Class C

Approving Authority

Sub Zonal Bangalore

Product Information

JAK2 V617F Mutation Detection Kit is a Real time PCR in vitro diagnostic kit for the detection of JAK2 (NeoDx) V617F allele in genomic DNA extracted from EDTA whole blood against a background of wild type genomic DNA. The mutation observed is a Guanine to Thymine transversion in position 1849 of the JAK2 gene, which leads to a valine to phenylalanine substitution in position 617 of the protein

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing